Our infrastructure

Our partnership with UCL has advanced digital/data science capabilities at UCLH, with the development of:

  • a hospitals-wide electronic health record (Epic), with embedded research functionality
  • a bespoke data analytics platform (EMAP)
  • Cloud-based supercomputing capabilities (Azure)
  • a trusted research environment, catalysed/coordinated by the BRC-supported Clinical Research Informatics Unit (CRIU). The CRIU bridges the NHS with UCL’s outstanding informatics, advanced research computing, computational science and AI-Centre.

NHS Partnerships

We have established partnerships with a range of NHS hospitals. With University Hospitals Birmingham and Alan Turing Institute, we established DECOVID, a UK-first in bringing rich multicentre hospital data on all admissions into a common data model (OMOP) in a Trusted Research Environment (TRE).

Across our Integrated Care System, we partner with the Whittington and Royal Free Hospitals, GOSH, and Health Services Laboratories.

UCLH partners with 30 hospital groups In NIHR Health Informatics Collaborative, demonstrating how sharing of NHS clinical information, held electronically, can facilitate more effective clinical research, leading to benefits for patients and the public, researchers and NHS staff. UCLH is the lead site for the Critical Care, Hearing Health, Myeloma & Transfusion-Dependant Anaemia themes.

Health Data Research UK (HDRUK)

HDRUK, seeks to unite the UK’s health data to enable discoveries that improve people’s lives. We are leading multiple projects across public health, trials, phenomics, and within the HDRUK- BHF Data Science Centre. We lead the first pan-London research collaboration (HDRUK London) partnership of all five of London’s major universities in biomedicine and health.

International collaborations

We have leading roles within multiple international research collaborations, including Stanford, Vanderbilt and multiple EU funded projects.

Industry Partnerships

We have developed strategic partnerships with industry, with Microsoft Research, GSK, focussing on diagnostics and patient flows, with GSK reproducible EHR phenotyping for genetic approaches to drug discovery and target validation, with AZ, Bayer, and Novartis on real world evidence.